-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Different Option in the Treatment of Transfusion-Dependent Anemia in Lower-Risk MDS

Sponsor: Geron
Program: Product Theaters
Hematology Disease Topics & Pathways:
Bone Marrow Failure Syndromes, Diseases, Myeloid Malignancies
Monday, December 9, 2024: 12:15 PM-1:15 PM
Room 2 (San Diego Convention Center)
Speaker:
Shyamala Navada, MD, Geron Corporation
Disclosures:
No relevant conflicts of interest to declare.
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>